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The virus plaque assay has been developed as a potential method for enumer- 
ating  immunologically activated lymphocytes. It  is based  on the observation 
that, while resting lymphocytes are nonpermissive for a variety of RNA viruses, 
lymphocytes activated by antigens or mitogens are capable of producing virus. 
When a population of activated lymphocytes is infected with vesicular stomatitis 
virus (VSV) 1 and plated in agar above a monolayer of L cells, infectious centers 
or plaques  are  produced in the  indicator layer by individual  virus-producing 
lymphocytes (1). 
A  variety of evidence has  accrued which  indicates that  this assay is selective for 
activated T relative to activated B lymphocytes in the mouse (2, 3). In human peripheral 
blood mononuclear cells, increases in virus plaque-forming cells (V-PFC) are found after 
stimulation with T-cells mitogens, e.g., phytohemagglutinin (PHA) or concanavalin A 
(Con A), but not with a B-cell mitogen, Staphylococcus aureus, of the Cowan I strain (3, 
4). 
In earlier studies on development of  V-PFC in peripheral blood lymphocytes of  tubercu- 
lin-sensitive human donors stimulated by purified protein derivative (PPD), it was found 
that the development of V-PFC was not inhibited by agents blocking mitosis and DNA 
synthesis  (5). From these  studies  it  was  concluded that  at  least  some  V-PFC  were 
antigen-sensitive, nondividing cells, and it was suggested that there might be an effector 
cell population  in delayed type hypersensitivity with  similar  properties.  Subsequent 
studies  on the development of V-PFC  in primary mixed lymphocyte cultures  (MLC), 
however,  indicated that  the  development of V-PFC  was  totally inhibited  by mitotic 
inhibitors. Further, the V-PFC detected in the I ° MLC primarily responded to determi- 
nants coded for by I  region genes, and not by those coding for H-2D or K end products 
which might have been expected of cytotoxic T lymphocytes (6). Anti-Ia sera directed 
against  stimulating cells totally blocked development of V-PFC, while the same sera 
directed against determinants on the responding cells had no more effect than normal 
mouse sera in inhibiting V-PFC (7). 
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The introduction of isoimmune sera which can distinguish functional T-cell subpopula- 
tions has made it experimentally possible to distinguish between T  cells responsible for 
helper activity, suppressor activity,  MLC reactivity,  and H-2 cytotoxic activity. 
The purposes of the present experiments were to define the T-cell subpopula- 
tion(s) detected by the virus plaque assay and to resolve the question whether 
cell proliferation was required for development of effector function and virus 
formation  by  these  subpopulations.  It  was  of special  interest  to  ascertain 
whether cytotoxic T cells (CTL) could be enumerated by the virus plaque assay. 
Materials and Methods 
Animals.  2-mo old mice of the C57B1/6,  C57B1/10  (H-T), DBA/2 (H-2d), and congenic C57B1/ 
10.D2 (B10.D2)  strains were purchased from The Jackson Laboratory, Bar Harbor, Maine. 
Immunization.  C57Bl (H-2  b) mice were immunized against H-2  d alloantigens by intraperito- 
neal injection of 107 P815 mastocytoma cells maintained in DBA/2 mice. For studies on secondary 
responses of these primed animals, spleen cells were obtained 14-80 days after immunization. 
Mixed Lymphocyte Cultures.  In each experiment spleen cell suspensions were prepared from 
normal and primed mice. Single cell suspensions were obtained by teasing the spleens in fetal calf 
serum  and pressing them  through  a  60-mesh stainless screen into  Eagle's  minimal essential 
medium (MEM) containing penicillin (100 U/ml), streptomycin (100 ftg/ml), and giutamine (200 
mM). Cells were washed, resuspended in MEM supplemented with 20% FCS to a density of 5 x  107 
viable cells/ml. Responding cells in the MLC were generally filtered through nylon wool columns 
for enrichment of T  cells by the method of Julius et al.  (8).  The nonadherent cells,  after two 
washes, were resuspended in complete RPMI 1640 medium (Grand Island Biological Co., Grand 
Island, N.Y.) containing 5% fetal calf serum (Flow Laboratories, Inc., Rockville, Md.), penicillin 
and streptomycin as above. In addition 2-mercaptoethanol was added at 5  ×  10 -s M. 
Stimulator  cells  or  whole  spleen  cells  were  treated  with  mitomycin  C  (50  pg/ml,  Sigma 
Chemical Co., St. Louis, Mo.) for 30 min at 37°C,  at a cell density of 107 viable cells/ml. For mixed 
lymphocyte cultures, 5 ×  108 stimulator and 5 x  10  e responder cells were mixed in 2 ml of 5% fetal 
calf serum  (FCS)-RPMI  1640  and  cultured  in  16-ram  wells  of Linbro  culture  trays  (Linbro 
Chemical Co., New Haven, Conn.) (catalogue no. FB 16-24TC) for 24 or 48 h in most experiments, 
at  37°C  in  a  humidified  atmosphere  containing  7%  CO2  in  air.  For  some  cultures,  cytosine 
arabinoside (Ara C, catalogue no. 2135,  Sigma Chemical Co.) was added to appropriate samples at 
a  final concentration of 10 pg/ml at the initiation of culture. 
For in vitro sensitization ofT cells, the method of Cerottini et al. (9) was used.  Normal C57B1 
spleen cells (25  x  10  e) were admixed with an equal number of mitomycin C-treated DBA/2 or 
B10.D2 stimulator cells in 30-ml culture flasks. The cells were collected after 13 days in culture, 
their viability determined by trypan blue exclusion and they were stimulated in secondary MLC 
as described above. 
Controls in all experiments included responding cells cultured alone, generally by using 2.5 × 
10  ~ primed  or  unprimed  C57B1  spleen  T  cells  added  to  an  equal  number  of the  same  cells, 
mitomycin C-treated. 
Isolation of Ly Subclasses.  Anti-Ly 1.2 and anti-Ly 2.2 +  Ly 3.2 sera generously provided for 
these studies were prepared by Dr.  E.  A. Boyse, Memorial Sloan Kettering Cancer Center, and 
absorbed and calibrated by Dr. Harvey Cantor, Department of Medicine, Harvard Medical School. 
Methods for their preparation have been previously described in detail (10-12). 
For isolation of Ly subclasses, 50  ×  106/ml nylon wool-purified responder cells were incubated 
with Ly antiserum at a final dilution of l/4o-l/so in phosphate-buffered saline (PBS) containing 10% 
FCS for 30 min at room temperature.  After washing once, the cells were suspended in  1 ml of 
selected rabbit serum as a source of complement diluted 1:12 in PBS and incubated for another 30 
min at 37°C  (13). 
Determination of Cell Proliferation.  At the appropriate time after culture in I ° or II  ° MLC, 2 x 
105 viable cells were transferred into microtiter plates in 0.2 ml of 5% FCS-RPMI 1640 and pulsed 
for 6 h with 2 ~Ci of [3H]thymidine (New England Nuclear, Boston, Mass., sp act 2 Ci/mM). Cells 
were harvested in a  Titertek  multiple cell culture harvester  (Skatron A/S,  Flow Laboratories, ANNA  SENIK  AND  BARRY  R.  BLOOM  13 
Inc.,  Rockville,  Md.)  and  radioactivity  was  counted  in  a  Beckman  LS-230  liquid  scintillation 
counter (Beckman Instruments, Inc., Cedar Grove, N.J.) at 33% efficiency. 
Assay for CTL.  The assay for CTL was based on that described by Cerottini and Brunner (14). 
Because of the complexity of the experimental procedures being carried out on the responding 
cells, in most experiments cytotoxicity was assayed at 16 rather than 6 h, although in a  smaller 
number of experiments 6-h data were obtained and the pattern of response found to be identical. 
P815 mastocytoma cells, maintained by serial passage in DBA/2 mice were labeled with 100 ~Ci of 
5~Cr and washed and 5 x  104 labeled cells were added to 2 x  106 viable lymphocytes obtained from 
the MLC in 12 × 75-mm culture tubes containing 1 ml 5% FCS-RPMI 1640 (Grand Island Biological 
Co.). The tubes were incubated at 37°C in an atmosphere of 7% CO2. At the end of the incubation 
period, generally 16 h, the cells were centrifuged at 900 g  for 10 min, and 0.5 ml of supernates were 
transferred with an Eppendorf pipette into new tubes and counted in an LKB gamma counter. 
(LKB Instruments, Inc.,  Rockville, Md.)  Specific 51Cr release was calculated by the method of 
Cerottini and Brunner by using spontaneous leakage and freeze-thaw controls (14). 
Virus Plaque Assay.  The  virus  plaque  assay  was  performed  according to the  method des- 
scribed by Kano et al.,  and Jimenez and Bloom  (2,  15).  Cells were obtained from the MLC  at 
various times (2 x  l0  s viable cells), washed and infected with VSV at a multiplicity of infection of 
50 PFU/cell. The number of  specifically  activated V-PFC (AV-PFC) was calculated as  follows:  AV° 
PFC/103 = V-PFC/103 stimulated cells  - V-PFC/103 nonstimulated cells. 
Results 
Relationship  between  Cell Proliferation,  Cytotoxicity,  and  Generation  of V- 
PFC.  The principal model for study in these experiments has been a II  ° MLC 
reaction since it generates considerably more CTL than primary reactions (9). A 
comparison of the kinetics of thymidine incorporation,  T-cell cytotoxicity, and 
the formation of V-PFC in I ° and II  ° MLC (Fig. 1) indicates that previous immu- 
nization accelerates the tempo of reactivity and increases the peak reactivity of 
cytotoxic T cells and V-PFC, with little change in the development of proliferat- 
ing activity. Introduction of Ara C, a potent inhibitor of cellular DNA synthesis, 
into the primary MLC resulted in the total inhibition of development of CTL and 
V-PFC during the first 24 h. These activities remained at those levels for at least 
48 h,  although  greater numbers of both were found after 48 h  in cultures not 
treated with Ara C. Identical results (data not shown) were obtained from lym- 
phocytes previously stimulated in vitro in a I ° MLC and later re-exposed to allo- 
geneic cells in a II  ° MLC. These experiments indicated that in II  ° MLC develop- 
ment of V-PFC and CTL paralleled one another,  and these functions appeared 
to be carried out both by dividing cells and by cells capable of differentiation 
without cell division. 
Effect of VSV Preinfection on Development of Cytotoxic T Cells.  We have pre- 
viously found that preinfection of resting lymphocytes with VSV later followed 
by stimulation by mitogens or allogeneic cells resulted in a dramatic inhibition 
of thymidine incorporation by the preinfected cells. We have interpreted these 
results  to  indicate  that  resting  lymphocytes are  capable of being infected by 
lytic viruses, but that the infection remains latent or persistent until the cells 
are activated (3,  16). Since VSV is a  lytic virus, stimulation of the preinfected 
cells resulting in activation of the virus is a lethal event for the cell. Because of 
the parallelism in the kinetics of CTL and V-PFC, the possibility of eliminating 
these cells by preinfecting them with virus was suggested. Accordingly, immune 
spleen cells were infected overnight with VSV at a multiplicity of infection of 25. 
After three washings, the cells were restimulated by allogeneic cells in the pres- 
ence of Ara C. As shown in Fig. 2, preinfection resulted in an almost total elimi- 14 
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Fro.  1.  Lymphocyte activation in primary and secondary MLC as detected by the VPA, 
5~Cr-release  and incorporation of [3H]thymidine. Responder cells in secondary MLC were 
primed 21 days before  MLC. Solid lines indicate response in culture medium alone; dotted 
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FIG.  2.  Effect of preinfection of lymphocytes with VSV on development of CTL in second- 
ary MLC. Lymphocytes obtained 24 days after sensitization were infected with VSV for 24 h 
or cultured in medium alone before stimulation with allogeneic cells. Solid line, noninfected 
responder cells; dotted line, VSV preinfected responder cells; box, noninfeeted responding 
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TABLE  I 
Comparison  between Unfractionated  Immune Spleen Cells and T-Cell Subpopulations 
in H ° MLC (21 Days after Primary Immunization) 
Specific  Ineorpora- 
Cells  Treatment  Killed  AV-PFC/  S~Cr  tion of  V-PFC  Cytotox-  [SH]Thymi'dine  incor- 
10~  release  [SH]thymi"  icity  poration 
dine 
%  %  %  % 
(A) Unfractionated  NMS  18.7  6.84  58.5  21,900  100  100  100 
(B)  Ly 1  anti-Ly 2  28.5  4.95  12.0  15,100  72  21  70 
(C)  Ly 2, 3  anti-Ly 1  36.4  2.20  88.4  4,800  32  156  21 
(B + C) Ly 1 + Ly 2, 3  6.61  50.8  14,890  98  90  88 
nation of cytotoxic activity 48 h after stimulation whereas Ara C resulted in only 
a 50% diminution. These data directly indicate that VSV can infect and inac- 
tivate those T cells capable of differentiating upon contact with antigen into 
cytotoxic effector cells. 
Virus Production by Ly I  and Ly 2,3 Cells.  From the studies of Shiku et al. 
(11) and Cantor and Boyse and Cantor and Weissman (10, 12, 17) it would be ex- 
pected that T cells capable of generating cytotoxic activity in secondary MLC 
would express the Ly 2,3 phenotype, while T cells responsible for the majority 
of [3H]thymidine incorporation would have the Ly 1 phenotype. 
If our  interpretation of the  previous  experiments is  correct,  then  V-PFC 
should be contained in activated T cells of both the Ly 1 and Ly 2,3 populations. 
Table I illustrates the responses of spleen T cells from donors primed 21 days 
earlier with allogeneic cells after treatment with anti-Ly 1 and anti-Ly 2,3 sera. 
Ly 1 cells were responsible for 70% of V-PFC, while Ly 2,3 cells accounted for 
30% of V-PFC. These relative proportions were found to be remarkably constant 
among six experiments carried out by using primed spleen cells, treated with 
the Ly isoantisera and boosted in vitro over a wide range of times after primary 
immunization  (see  below,  and  Fig.  4).  Reconstitution of cells  treated with 
anti-Ly 1 and cells treated with anti-Ly 2 serum produced a population deficient 
in Ly 1,2,3 cells, and this Ly 1 + Ly 2,3 mixture contained the same level of  virus 
plaque-forming activity as found in untreated cells.  Since the precise number of 
Ly 1,2,3 cells in the population is not known, it is not possible formally to ex- 
clude the possibility that some V-PFC were of this phenotype, although their 
contribution could not be great. 
Discrimination  between Memory T  Cells and Prekiller T  Cells.  The data in 
Table I  indicate that the stimulated Ly 2,3  cells incorporated threefold less 
[3H]thymidine than comparable numbers of Ly 1 cells. The question of most 
interest to us, however, was whether Ly 2,3 memory cells for cytotoxicity re- 
quired proliferation to differentiate into functional killer T cells after restimula- 
tion with alloantigens. To clarify this question, the differing patterns of virus 
plaque-forming activity of the T-cell subclasses were studied in the presence and 
absence of Ara C (Fig.  3). It emerged that unfractionated spleen cells obtained 
approximately 3 wk after immunization, and restimulated 24-48 h in the pres- 
ence of Ara C generated approximately the same number of V-PFC as the Ly 2,3 
population alone or in the presence ofAra C. These results demonstrate that the 
primed Ly 2,3 population can be activated by alloantigens to produce virus and 
cytotoxicity in the absence of proliferation. This result further suggested the 16  DIFFERENTIATION  OF  MEMORY  T  CELLS 
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FIG.  3.  Contribution of T-lymphocyte subpopulations to V-PFC (21 days). 
possibility that if this were an invariant  function of Ly 2,3 memory cells, then 
their number could be estimated without the necessity of anti-Ly 1 treatment 
simply by addition ofAra C to the cultures. However, when similar experiments 
were carried out by using spleen cells from donors primed for longer periods of 
time (Fig. 4), it was found that an increasing proportion of Ly 2,3 differentiation 
to V-PFC and cytotoxic effector cells was dependent on cell proliferation.  At 80 
days after priming,  for example,  essentially all of the  Ly 2,3 cells capable of 
being activated could be inhibited by addition of Ara C, as measured both in the 
virus plaque assay in the cytotoxic test.  In both assays there was a  complete 
agreement between the results of NMS plus Ara C treatment and anti-Ly 1 plus 
Ara  C  treatment  indicating  that  the proliferation  at later  times  was truly  a 
property of the Ly 2, 3 cells, and independent of effects mediated by the Ly 1 cell. 
In this situation  (data not shown), there was a  marked increase in [3H]thymi- 
dine  incorporation  by the  stimulated  Ly 2,3  cells,  essentially  comparable  to 
that given by the Ly 1 cells at this time. 
These results  indicate  that  the  longer  after immunization,  the  greater the 
number of Ly 2,3 cells requiring a proliferative stage before acquiring the capa- 
bility of producing virus or carrying out cell-mediated cytotoxicity. In this re- 
gard, these cells behave as true memory cells, requiring both additional antigen 
stimulation  and cell proliferation to differentiate fully into competent effector 
cells. 
Discussion 
These  experiments  were designed  to clarify two general  questions:  (a)  the 
functional  nature  and subpopulation characteristics  of the T  cells detected by 
the virus plaque assay; and (b) whether cell proliferation was required for acqui- 
sition of effector function and ability to replicate virus by these subpopulations. 
We have chosen II  ° MLC as the system for study both because high levels of T- 
cell proliferation and cytotoxicity are generated (9, 18, 19) and because the sub- 
populations carrying out these functions have been defined by anti-Ly isoanti- ANNA  SENIK  AND  BARRY  R.  BLOOM  17 
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Fro.  4.  Differentiation  of memory  cells obtained at various intervals after immunization 
into V-PFC and CTL. O-O, unfractionated spleen lymphocyte  preparation; [3-[3,  Ly 1 
cells. A-A, Ly 2,3 cells. Solid line, cells cultured in medium alone; dotted line, cells 
cultured in medium  containing Ara C. 
sera.  Cantor and Boyse have demonstrated in the same MLC combination as 
used here that the proliferating T cell has the Ly 1 phenotype and the CTL has 
the Ly 2,3 phenotype, and that both functional subpopulations derive from an 
Ly 1,2,3 precursor cell (17, 19). 
In previous studies on murine spleen cells, marked stimulation in V-PFC was 
produced by T-cell mitogens such as PHA, Con A, or pokeweed mitogen; much 
smaller or negligible responses were produced by the B-cell mitogen lipopoly- 
saccharide. In I  ° MLC the V-PFC was found to be completely eliminated by treat- 
ment, either before or after culture, with anti-thy 1 serum plus complement, 
formally demonstrating that it was a T cell (2). 
In the present experiments an accelerated course of development of V-PFC 
has been observed in secondary MLC as compared with primary MLC, as has 
been found to be the case in assays for incorporation of thymidine and T-cell 
cytotoxicity. When spleens primed in vivo or in vitro were subjected to treat- 
ment with anti-Ly 1 or anti-Ly 2,3 sera plus complement, a relatively constant 
percentage of V-PFC was eliminated (Table I, Figs. 3 and 4).  Anti-Ly 1  +  C 
treatment reduced the number of V-PFC above background by approximately 
70%, and treatment with anti-Ly 2,3 serum plus complement reduced the num- 
ber of V-PFC by approximately 30%. While reconstitution experiments failed to 
indicate that activated Ly 1,2,3 cells are detected by the virus plaque assay that 
possibility cannot be formally excluded. 
We believe that the present data provide three lines of  evidence to support the 
contention that the virus plaque assay, in addition to detecting the proliferating 
Ly 1-type T cell, is capable of detecting cytotoxic T  lymphocytes. First, in the 
presence of Ara C in the II  ° MLC, there is a clear parallel in the development of 
cytotoxic T  lymphocytes and V-PFC in the total absence of [3H]thymidine in- 
corporating cells (Fig. 1). Secondly, treatment with anti-Ly 2,3 serum + C elimi- 
nates 30% of the V-PFC and essentially 100% of the cytotoxic activity, without 
significantly diminishing  incorporation  of  [3H]thymidine  (Table  I,  Fig.  3). 18  DIFFERENTIATION  OF  MEMORY  T  CELLS 
Lastly, in previous studies it has been reported that resting lymphocytes can 
be infected by VSV, and this infection remains latent or persistent until the cells 
are activated (3,  16). In the present experiments, preinfection of responding 
primed spleen cells with VSV for 24 h, followed by stimulation in vitro resulted 
in the total elimination of cytotoxic T cells at 48 h, under conditions in which 
simply inhibition of cell proliferation, with Ara C,  would have resulted in a 
diminution of only 50%. These results provide direct evidence that the cytotoxic 
T lymphocyte is detected by the virus plaque assay. 
The level of study in the present experiments has been primarily a qualitative 
one, and optimal conditions for quantitative detection of the actual number of 
V-PFC or cytotoxic T lymphocytes have not yet been established. With indirect 
estimations of the number of CTL in different experimental circumstances, dif- 
ferent laboratories have obtained often widely divergent estimates.  For ex- 
ample, Fitch et al. (18) in repeated in vitro boosting experiments estimate maxi- 
mally 33% of surviving lymphocyes must be CTL.  In limiting dilution studies 
Bach et al. (20) have estimated the number of CTL in a II  ° MLC to be 0.1-1%, and 
most recently Thorn and Henney (21) have provided an estimate of approxi- 
mately 0.8-2%. The data in the virus plaque assay are comparable to the latter 
figures, although this figure is a minimum estimate since it is unlikely that the 
VPA is detecting all activated T cells of any class. 
The second major concern of this work has been to resolve the apparent dis- 
crepancies in different systems on whether cell division is required for differen- 
tiation of memory cells into effector cells in cell-mediated immunity. Previous 
studies on development of V-PFC in vitro after stimulation of tuberculin-sensi- 
tive human lymphocytes by PPD had indicated that the development of V-PFC 
was not inhibited by the mitotic inhibitors, vinblastine or Ara C (5). These ex- 
periments suggested the existence of an antigen-sensitive nondividing cell, and 
it was proposed that such cells would be short lived and have effector function 
in cell-mediated immune reactions. While this point has been controversial, it 
has subsequently been reported that not only V-PFC, but T-cell helper activity 
(22), migration inhibitory factor production (23, 24), and T-cell cytotoxicity (25- 
27) may be generated in secondary responses from memory cells in the absence 
of cell proliferation. 
In the present experiments comparison of the effects of Ara C on the develop- 
ment of I  ° and II  ° MLC confirmed that in primary MLC all in vitro functions 
measured in the primary response, namely incorporation of [3H]thymidine, de- 
velopment of CTL, and V-PFC were abolished by the inhibitor of DNA synthe- 
sis. In contrast, in II  ° MLC by using spleen cells from recently primed animals, 
there was essentially no diminution either in V-PFC or CTL in the first 48 h of 
culture (Fig.  4). These observations suggested the possibility that it might be 
possible  to estimate the number of CTL in other species for which anti-Ly-like 
isoantisera are not available simply by carrying out the VPA in the presence of 
inhibitors of DNA synthesis. However, systematic study showed that the devel- 
opment of both CTL and V-PFC responses of Ly 2,3 cells became progressively 
more susceptible to Ara C as the time interval between primary immunization 
and in vitro boosting was increased (Fig. 4). 
Thus, there appears to be a marked difference in the immediate precursor to 
the CTL and V-PFC depending on time after contact with antigen. One possible ANNA  SENIK  AND  BARRY  R.  BLOOM  19 
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FIG.  5.  Model for differentiation of CTL. Both Ly i and Ly 2,3 cells derive from a common 
precursor which is Ly 1,2,3 positive (17). The inhibition of all functions in I ° MLC by Ara C 
indicates that the early differentiation process requires cell proliferation.  Subsequent to 
antigen stimulation,  Ly  2,3  memory cells arise which are defined by their ability upon 
further contact with specific antigen to differentiate into functional CTL after one or more 
cell divisions.  In the scheme, the amplifying effect of the Ly 1 proliferating T  cells,  or a 
product derived from them (wavy lines) is viewed as being most important during the initial 
stages  of differentiation.  The  present data  would  suggest  that there  is  an  Ly  2,3  cell, 
incapable of carrying out effector function without further antigen stimulation, but capable 
of differentiating into a  CTL  or V-PFC  without division.  We have termed this antigen- 
sensitive, nondividing cell a  prekiller cell. 2 Since pre-killer cells are not found in spleens 
late after immunization, it may be inferred that they are short-lived cells. 
model for visualizing this process of T-cell differentiation is illustrated in Fig. 5, 
and is analogous to models for differentiation of B cells proposed by Askonas 
and Williamson (28). 
The discrepancy between the number of actual killer cells at a  given time, 
particularly late after immunization, and the number of CTL capable of being 
generated by further exposure of memory cells to antigen raises the question of 
which of these two parameters is more likely to be a useful index of the effector 
function in clinical states.  For example, if this scheme applied to the specific 
effector cells operative against tumor antigens, it is conceivable that at any 
given time in some patients there might be very few directly measurable cyto- 
toxic T ]ymphocytes, but a rather large pool of memory cells capable of differen- 
tiating into cytotoxic lymphocytes. In other patients, there might be a  negli- 
gible pool of memory cells. For this reason, we suggest that it may be important 
to attempt to measure not only the actual cytotoxic circulating cells in such indi- 
viduals, but also their cytotoxic potential,  i.e.,  the number of cytotoxic cells 
capable of being generated upon appropriate antigen stimulation in vitro. 
Summary 
The aims of this study were to define the T-cell subpopulation(s) detected by 
the virus plaque assay, and particularly to determine whether the virus plaque 
assay could be used to enumerate cytotoxic T lymphocytes. In addition, studies 
were undertaken to ascertain whether cell proliferation was required for devel- 
opment of cytotoxic effector function and virus plaque formation by these sub- 
populations. The results of experiments with a secondary mouse mixed lympho- 
cyte culture (MLC) model indicated that 70% of virus plaque-forming cells bore 
the Ly i phenotype and 30% the Ly 2,3 phenotype. Three lines of evidence sug- 
2 The term prekiller cell was originally used by Kamat and Henney (29) to designate a primed 
cell which acquired cytotoxic activity in the absence of antigen stimulation by culturing in me- 
dium alone. Such cells have been consistently observed in the present work as well but are dis- 
tinguished here from cells differentiating to CTL without division upon antigen stimulation. 20  DIFFERENTIATION  OF  MEMORY  T  CELLS 
gested that cytotoxic T  lymphocytes (CTL) can be detected by this  assay: the 
fact that some virus plaque-forming cells (V-PFC) bear the same Ly phenotype 
as CTL; the use of an inhibitor of DNA synthesis indicated that proliferating 
cells could be eliminated with no effect on V-PFC production and cytotoxic ac- 
tivity of the Ly 2,3 cell population; and that infection of primed lymphocytes 
with vesicular stomatitis virus before (MLC) stimulation eliminated cytotoxic 
activity. 
In primary MLC, development of V-PFC and CTL was completely abolished 
by cytosine arabinoside. In contrast, in secondary MLC, some CTL and V-PFC 
were generated by antigenic stimulation in the absence of proliferation. How- 
ever, the development of both functions became progressively more susceptible 
to cytosine arabinoside as the time between primary immunization and in vitro 
boosting is increased. It is suggested that there may be a considerable disparity 
between the number of existing effector cells at any given time and the cytotoxic 
potential, i.e. the number of  cells capable of  being generated by antigenic stimu- 
lation. 
The authors are deeply grateful to Dr. Harvey Cantor, Harvard Medical School, for his kindness in 
providing the calibrated anti-Ly sera and for his helpful advice and critical discussion of all stages 
of this work. 
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